Learning curves and breast cancer lymphatic mapping: Institutional volume index

被引:34
作者
Dupont, E [1 ]
Cox, C [1 ]
Shivers, S [1 ]
Salud, C [1 ]
Nguyen, K [1 ]
Cantor, A [1 ]
Reintgen, D [1 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Surg, Comprehens Breast Canc Program, Tampa, FL 33612 USA
关键词
D O I
10.1006/jsre.2001.6127
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction. To date, studies of breast cancer lymphatic mapping (LM) have analyzed success with respect to individual surgeons. However, LM and sentinel lymph node biopsy (SLNBx) are procedures that require institutional multidisciplinary cooperation between the departments of radiology, pathology, and surgery. Thus, it is important to evaluate these procedures with respect to the institution. This study examines 30 institutions to clarify the value of the institutional volume index (IVI) (cases/month) to the outcome of LM and SLNBx in breast cancer. Methods. From July 1997 to July 1999, 30 institutions participated in the Department of Defense national breast LM trial. All participants underwent a 2-day training course for surgeons, nuclear medicine physicians, and pathologists. The records for each institution were prospectively accrued and submitted to a database. The false negatives, failure rates, and IVI were calculated for each institution. A logistic regression model plots the relationship between IVI and institutional failure rate. Using a multivariate analysis, mapping failure was analyzed as a function of case number with respect to the individual surgeon and the institution as a whole. Results. False negative results were demonstrated in only 5 (4%) cases among all institutions and were excluded from further analysis due to small numbers. Mapping failures were found in all but 7 of the 30 institutions whose data were complete. There were 71 mapping failures among 74 surgeons over 555 cases, which yielded an overall failure rate of 12.79% (71 555). The logistic regression model revealed an inverse relationship between IVI and institutional failure rate. However, the multivariate analysis revealed that the individual surgeon performance was the most significant factor in determining institutional mapping success. Conclusion. Failure to map can be a function of multiple factors including surgical skill, surgical volume index, and injection method of the SLN patient, all under the quality control of an institution. The surgical failure rate on the other hand is a function of surgical skill, surgical volume, and injection methods. While differences in mapping success exist across institutions, this disparity is not due to factors associated with the institution as a whole, but lie with the individual surgeon. (C) 2001 Academic Press.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 16 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]  
Bass S S, 1999, Surg Oncol Clin N Am, V8, P497
[3]  
COX C, 2000, SOC SURG ONC 53 ANN
[4]   Implementation of new surgical technology: Outcome measures for lymphatic mapping of breast carcinoma [J].
Cox, CE ;
Bass, SS ;
Boulware, D ;
Ku, NK ;
Berman, C ;
Reintgen, DS .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (06) :553-561
[5]  
Cox CE, 1998, ONCOLOGY-NY, V12, P1283
[6]   Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer [J].
Cox, CE ;
Bass, SS ;
McCann, CR ;
Ku, NNK ;
Berman, C ;
Durand, K ;
Bolano, M ;
Wang, J ;
Peltz, E ;
Cox, S ;
Salud, C ;
Reintgen, DS ;
Lyman, GH .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :525-542
[7]   Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer [J].
Cox, CE ;
Pendas, S ;
Cox, JM ;
Joseph, E ;
Shons, AR ;
Yeatman, T ;
Ku, NN ;
Lyman, GH ;
Berman, C ;
Haddad, F ;
Reintgen, DS .
ANNALS OF SURGERY, 1998, 227 (05) :645-653
[8]  
COX CE, 2000, MASTERY LYMPHATIC MA
[9]  
GUILIANO AE, 1994, ANN SURG, V220, P391
[10]  
KHUFI SF, 1999, ANN SURG, V230